Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials

(2015) José M Garcia et al.   LANCET ONCOLOGY

Ghrelin

(2015) T.D. Müller et al.   Molecular Metabolism

Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia

(2014) Liang-Kung Chen et al.   Journal of the American Medical Directors Association

Treatment of Cachexia: An Overview of Recent Developments

(2014) Stephan von Haehling et al.   Journal of the American Medical Directors Association

Validating the SARC-F: A Suitable Community Screening Tool for Sarcopenia?

(2014) Jean Woo et al.   Journal of the American Medical Directors Association

Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

(2014) David R. Fogelman et al.   Journal of Cachexia Sarcopenia and Muscle

Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure

(2014) Tuba Khawaja et al.   Journal of Cachexia Sarcopenia and Muscle

From sarcopenia to frailty: a road less traveled

(2014) John E. Morley et al.   Journal of Cachexia Sarcopenia and Muscle

Muscle wasting disease: a proposal for a new disease classification

(2014) Stefan D. Anker et al.   Journal of Cachexia Sarcopenia and Muscle

Are we closer to having drugs to treat muscle wasting disease?

(2014) John E. Morley et al.   Journal of Cachexia Sarcopenia and Muscle

An overview of amines as nutritional supplements to counteract cancer cachexia

(2014) Patrícia Lopes de Campos-Ferraz et al.   Journal of Cachexia Sarcopenia and Muscle

Formoterol in the treatment of experimental cancer cachexia: effects on heart function

(2014) Míriam Toledo et al.   Journal of Cachexia Sarcopenia and Muscle

Body composition and survival in the early clinical trials setting

(2013) H. Veasey Rodrigues et al.   EUROPEAN JOURNAL OF CANCER

Scientific overview of hormone treatment used for rejuvenation

(2013) John E. Morley   FERTILITY AND STERILITY

Low skeletal muscle is associated with toxicity in patients included in phase I trials

(2013) Sophie Cousin et al.   INVESTIGATIONAL NEW DRUGS

Muscle Quantity Is Not Synonymous With Muscle Quality

(2013) Sébastien Barbat-Artigas et al.   Journal of the American Medical Directors Association

Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group

(2013) Jürgen Bauer et al.   Journal of the American Medical Directors Association

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

(2013) Adrian S Dobs et al.   LANCET ONCOLOGY

Why cachexia kills: examining the causality of poor outcomes in wasting conditions

(2013) Kamyar Kalantar-Zadeh et al.   Journal of Cachexia Sarcopenia and Muscle

Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis

(2013) Ian C. Scott et al.   Journal of Cachexia Sarcopenia and Muscle

Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case-control study

(2013) Aurelius Omlin et al.   Journal of Cachexia Sarcopenia and Muscle

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

(2013) Mareike S. Pötsch et al.   Journal of Cachexia Sarcopenia and Muscle

Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS)

(2013) Michael Knops et al.   Journal of Cachexia Sarcopenia and Muscle

Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial

(2013) Manoch Rattanasompattikul et al.   Journal of Cachexia Sarcopenia and Muscle

Pathophysiology of the anorexia of aging

(2012) John E. Morley   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Consensus on Cachexia Definitions

(2010) Josep M. Argilés et al.   Journal of the American Medical Directors Association